Jan Skvarka
Director/Board Member bij ZENTALIS PHARMACEUTICALS, INC.
Vermogen: 533 153 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Jan Skvarka
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 22 | |
| Unknown | 19 | ||
| Public Company | Biotechnology | 17 | |
GentiBio, Inc.
 GentiBio, Inc. BiotechnologyHealth Technology GentiBio, Inc. engages in the development of engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory, and allergic diseases. The company was founded by Adel Nada, David Rawlings, Jane H. Buckner, and Gideon Gross and is headquartered in Seattle, WA.
7
| Holding Company | Biotechnology | 7 |
DEM BioPharma, Inc.
 DEM BioPharma, Inc. Pharmaceuticals: MajorHealth Technology DEM BioPharma, Inc. is an American company that pioneers the next generation of immunotherapeutics to eliminate tumors by targeting 'don't eat me' and 'eat me' signals on cancer cells, macrophages, and other myeloid effector cells. The company is based in Cambridge, MA. The proprietary CHOMP™ platform utilizes CRISPR-based functional genomic screens to discover and validate new signals that could enhance cancer cell elimination through increased phagocytosis. The company was founded by Longwood Fund and builds on groundbreaking functional genomics research and discoveries in macrophage biology from its scientific co-founders. Nenad Grmusa has been the CEO of the company since 2022.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jan Skvarka via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Chairman | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chairman | |
Kalyra Pharmaceuticals, Inc.
 Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kalyra Pharmaceuticals, Inc. manufactures small molecule drugs. The company was founded by Brian T. Dorsey, Cam L. Garner and Kevin Bunker and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Founder | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Indiana University | College/University | Undergraduate Degree Graduate Degree | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Doctorate Degree | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Director/Board Member Founder | |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman Director of Finance/CFO | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
| ALLAKOS INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Infinant Health, Inc.
 Infinant Health, Inc. BiotechnologyHealth Technology Infinant Health, Inc. develops novel solutions to resolve the dysbiosis. It develops a probiotic bacteria activated with specific prebiotic oligosaccharides and delivery systems to provide and maintain a healthy microbiome in infants during the first six months of life. The company is headquartered in Davis, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Monte Rosa Therapeutics AG
 Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
Dren Bio, Inc.
 Dren Bio, Inc. BiotechnologyHealth Technology Dren Bio, Inc. operates as a biotechnology company. It focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. The company was founded by John Wesley and Nenad Tomasevic in 2019 and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Lengo Therapeutics, Inc.
 Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lengo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer Chairman | |
Superluminal Medicines Inc
 Superluminal Medicines Inc BiotechnologyHealth Technology Superluminal Medicines Inc is a generative biological and chemical company. The company is based in Boston, MA. The CEO of the company is Cony D'Cruz. | Biotechnology | Director/Board Member Director/Board Member | |
Bright Peak Therapeutics, Inc.
 Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The private company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member Founder |
Statistieken
Internationaal
| Verenigde Staten | 42 |
| Canada | 4 |
| Verenigd Koninkrijk | 4 |
| Zwitserland | 3 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Finance | 4 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 313 |
| Corporate Officer/Principal | 120 |
| Independent Dir/Board Member | 91 |
| Chairman | 55 |
| Doctorate Degree | 41 |
Sterkste connecties
| Insiders | |
|---|---|
| Daniel Janney | 47 |
| Calvin Stiller | 38 |
| Andrew Schiff | 35 |
| Ali Behbahani | 34 |
| Catherine Mackey | 24 |
| Cam Gallagher | 24 |
| Chandra Paul Leo | 22 |
| Luke Beshar | 19 |
| Scott Myers | 18 |
| Alexander Mayweg | 18 |
| Michael G. Moore | 16 |
| Christine Siu | 15 |
| Kyle Rasbach | 15 |
| Michael Kamarck | 15 |
| Paolo Pucci | 15 |
- Beurs
- Insiders
- Jan Skvarka
- Bedrijfsconnecties
